Clinical trial
The Performance of Visuprime in Improving Ocular Surface Homeostasis and Reducing Conjunctival Bacterial Load in Patients Receiving Cataract Surgery
NCT06533995 is registered in ClinicalTrials.gov with VISUfarma SpA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Performance of Visuprime in Improving Ocular Surface Homeostasis and Reducing Conjunctival Bacterial Load in Patients Receiving Cataract Surgery
- Lead sponsor
- VISUfarma SpA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 25, 2021
- Completion date
- February 22, 2022
- Enrollment
- 75 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.